Prostate cancer (PCA) is the most common solid cancer among European men with a
continuously increasing incidence. Adequate management and follow-up of PCA relies not …

Despite recent improvements in detection and treatment, prostate cancer continues to be the
most common malignancy and the second leading cause of cancer-related mortality. Thus …

Prostate cancer (PCa) is the second most common malignant tumor in men, with an
incidence of over 1.4 million worldwide. The prevalence of PCa rises with each successive …

Prostate Cancer Imaging: What We Already Know and What Is on the Horizon | RadioGraphics
RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu Home Journals All Journals …

Prostate cancer is the most common malignancy in men, in general. Most patients
diagnosed with prostate cancer have localized disease confined to the prostate. A small …

The development of prostate cancer imaging is rapidly evolving, with many changes to the
way patients are diagnosed, staged, and monitored for recurrence following treatment. New …

The imaging of prostate cancer at different disease states has undergone a series of
quantum leaps in the past decade. Imaging in prostate cancer serves, in part, the purpose of …

The current diagnosis and management of prostate cancer is largely based on the use of
serum prostate-specific antigen (PSA) and pathologic risk factors such as Gleason score …

Prostate cancer (PCa), which is among the most prevalent types of cancer in men, is a
prominent topic in imaging research. The primary aim of PCa imaging is to acquire more …

No consensus exists at present regarding the use of imaging for the evaluation of prostate
cancer. Ultrasonography is mainly used for biopsy guidance and magnetic resonance …